Genedx Holdings Corp Stock Buy Hold or Sell Recommendation
WGS Stock | 78.58 6.51 9.03% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding GeneDx Holdings Corp is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell GeneDx Holdings Corp given historical horizon and risk tolerance towards GeneDx Holdings. When Macroaxis issues a 'buy' or 'sell' recommendation for GeneDx Holdings Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out GeneDx Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as GeneDx and provide practical buy, sell, or hold advice based on investors' constraints. GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
GeneDx |
Execute GeneDx Holdings Buy or Sell Advice
The GeneDx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on GeneDx Holdings Corp. Macroaxis does not own or have any residual interests in GeneDx Holdings Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute GeneDx Holdings' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Hold
Market Performance | Good | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
GeneDx Holdings Trading Alerts and Improvement Suggestions
GeneDx Holdings Corp is way too risky over 90 days horizon | |
GeneDx Holdings Corp appears to be risky and price may revert if volatility continues | |
The company reported the last year's revenue of 202.57 M. Reported Net Loss for the year was (175.77 M) with loss before taxes, overhead, and interest of (26.75 M). | |
GeneDx Holdings generates negative cash flow from operations | |
GeneDx Holdings Corp has a frail financial position based on the latest SEC disclosures | |
About 70.0% of the company outstanding shares are owned by institutional investors | |
Latest headline from thelincolnianonline.com: Katherine Stueland Sells 22,307 Shares of GeneDx Holdings Corp. Stock |
GeneDx Holdings Returns Distribution Density
The distribution of GeneDx Holdings' historical returns is an attempt to chart the uncertainty of GeneDx Holdings' future price movements. The chart of the probability distribution of GeneDx Holdings daily returns describes the distribution of returns around its average expected value. We use GeneDx Holdings Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of GeneDx Holdings returns is essential to provide solid investment advice for GeneDx Holdings.
Mean Return | 1.35 | Value At Risk | -6.05 | Potential Upside | 9.09 | Standard Deviation | 7.43 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of GeneDx Holdings historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
GeneDx Holdings Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to GeneDx Holdings or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that GeneDx Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a GeneDx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.28 | |
β | Beta against Dow Jones | 0.63 | |
σ | Overall volatility | 7.53 | |
Ir | Information ratio | 0.17 |
GeneDx Holdings Volatility Alert
GeneDx Holdings Corp is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure GeneDx Holdings' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact GeneDx Holdings' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.GeneDx Holdings Fundamentals Vs Peers
Comparing GeneDx Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze GeneDx Holdings' direct or indirect competition across all of the common fundamentals between GeneDx Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as GeneDx Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of GeneDx Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare GeneDx Holdings to competition |
Fundamentals | GeneDx Holdings | Peer Average |
Return On Equity | -0.36 | -0.31 |
Return On Asset | -0.0827 | -0.14 |
Profit Margin | (0.31) % | (1.27) % |
Operating Margin | (0.10) % | (5.51) % |
Current Valuation | 1.98 B | 16.62 B |
Shares Outstanding | 27.47 M | 571.82 M |
Shares Owned By Insiders | 18.20 % | 10.09 % |
Shares Owned By Institutions | 70.24 % | 39.21 % |
Number Of Shares Shorted | 2.6 M | 4.71 M |
Price To Book | 9.68 X | 9.51 X |
Price To Sales | 7.41 X | 11.42 X |
Revenue | 202.57 M | 9.43 B |
Gross Profit | (26.75 M) | 27.38 B |
EBITDA | (136.46 M) | 3.9 B |
Net Income | (175.77 M) | 570.98 M |
Total Debt | 119.77 M | 5.32 B |
Book Value Per Share | 7.45 X | 1.93 K |
Cash Flow From Operations | (180.15 M) | 971.22 M |
Short Ratio | 3.56 X | 4.00 X |
Earnings Per Share | (3.09) X | 3.12 X |
Target Price | 80.83 | |
Number Of Employees | 1 K | 18.84 K |
Beta | 2.18 | -0.15 |
Market Capitalization | 1.98 B | 19.03 B |
Total Asset | 473.67 M | 29.47 B |
Retained Earnings | (1.3 B) | 9.33 B |
Working Capital | 123.52 M | 1.48 B |
Net Asset | 473.67 M |
Note: Disposition of tradable shares by Katherine Stueland of GeneDx Holdings at 74.3389 subject to Rule 16b-3 [view details]
GeneDx Holdings Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as GeneDx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About GeneDx Holdings Buy or Sell Advice
When is the right time to buy or sell GeneDx Holdings Corp? Buying financial instruments such as GeneDx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having GeneDx Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rubber and Plastic Products Thematic Idea Now
Rubber and Plastic Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Rubber and Plastic Products theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rubber and Plastic Products Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.